Bridgefront Capital, LLC Shockwave Medical, Inc. Transaction History

Bridgefront Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$191.17 - $325.63 $68,630 - $116,901	-359 Reduced 26.47%	997 $324,000
Q4 2023 Feb 14, 2024	SELL	$160.99 - $215.69 $49,262 - $66,001	-306 Reduced 18.41%	1,356 $258,000
Q3 2023 Nov 14, 2023	SELL	$194.33 - $283.97 $67,043 - $97,969	-345 Reduced 17.19%	1,662 $330,000
Q2 2023 Aug 14, 2023	BUY	$223.05 - $302.68 $447,661 - $607,478	2,007 New	2,007 $572,000
Q1 2021 May 17, 2021	SELL	$92.73 - $142.05 $245,641 - $376,290	-2,649 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$67.44 - $103.72 $178,648 - $274,754	2,649 New	2,649 $275,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.